Letter: ustekinumab dose intensification for loss of response—should we re-induce before shortening the dose interval? Author's reply

Uri Kopylov^*

^*Corresponding author for this work

Research output: Contribution to journal › Letter › peer-review

Original language	English
Pages (from-to)	565-566
Number of pages	2
Journal	Alimentary Pharmacology and Therapeutics
Volume	52
Issue number	3
DOIs	https://doi.org/10.1111/apt.15892
State	Published - 1 Aug 2020
Externally published	Yes

Access to Document

@article{45eaa32b7b8649e395d5e71f90b2e097,

title = "Letter: ustekinumab dose intensification for loss of response—should we re-induce before shortening the dose interval? Author's reply",

author = "Uri Kopylov",

year = "2020",

month = aug,

day = "1",

doi = "10.1111/apt.15892",

language = "אנגלית",

volume = "52",

pages = "565--566",

journal = "Alimentary Pharmacology and Therapeutics",

issn = "0269-2813",

publisher = "Wiley-Blackwell Publishing Ltd",

number = "3",

}

TY - JOUR

T1 - Letter

T2 - ustekinumab dose intensification for loss of response—should we re-induce before shortening the dose interval? Author's reply

AU - Kopylov, Uri

PY - 2020/8/1

Y1 - 2020/8/1

UR - http://www.scopus.com/inward/record.url?scp=85087760903&partnerID=8YFLogxK

U2 - 10.1111/apt.15892

DO - 10.1111/apt.15892

M3 - ???researchoutput.researchoutputtypes.contributiontojournal.letter???

C2 - 32656845

AN - SCOPUS:85087760903

SN - 0269-2813

VL - 52

SP - 565

EP - 566

JO - Alimentary Pharmacology and Therapeutics

JF - Alimentary Pharmacology and Therapeutics

IS - 3

ER -